Latest Early Cancer Detection News

Page 4 of 4
Imagion Biosystems has progressed its MagSense HER2 breast cancer imaging agent towards a pivotal Investigational New Drug application with the FDA, backed by a solid funding runway exceeding 13 quarters.
Ada Torres
Ada Torres
30 Apr 2025
Imagion Biosystems has secured a AU$3 million capital injection and resumed its collaboration with Siemens, setting the stage to prioritize FDA filings and advance its MagSense® HER2 breast cancer imaging program.
Ada Torres
Ada Torres
30 Jan 2025

Browse the archive

Full archive